Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: A differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray-Reference-Cited by-同舟云学术

Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: A differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray

Published:2001-12 Issue:12 Volume:32 Page:1392-1397
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Skacel Marek,Ormsby Adrian H.,Pettay James D.,Tsiftsakis Evangelos K.,Liou Louis S.,Klein Eric A.,Levin Howard S.,Zippe Craig D.,Tubbs Raymond R.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference31 articles.

1. Temporal trends in rates of prostate cancer: Declining incidence of advanced stage disease, 1974-1994;Newcomer;J Urol,1997

2. Biological determinants of cancer progression in men with prostate cancer;Stamey;JAMA,1999

3. Prognostic significance of Gleason score 3+4 versus 4+3 tumor at radical prostatectomy;Chan;Mod Pathol,2000

4. The relative amount of Gleason pattern 4 tumor and surgical margin status are independent prognostic factors in Gleason score 7 prostate carcinoma after radical prostatectomy;Skacel;Mod Pathol,2000

5. The impact of positive surgical margin and Gleason pattern 4 tumor on the biochemical failure after radical prostatectomy;Skacel;J Urol,2000

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of indolence in prostate cancer (Review);Experimental and Therapeutic Medicine;2022-03-28

2. “More men die with prostate cancer than because of it” - an old adage that still holds true in the 21st century.;Cancer Treatment and Research Communications;2021

3. Contemporary approach to active surveillance for favorable risk prostate cancer;Asian Journal of Urology;2019-04

4. Contemporary Active Surveillance;Urologic Clinics of North America;2017-11

5. Active Surveillance for Low-Risk Prostate Cancer;Management of Urologic Cancer;2017-06-09